甲状旁腺疾病

甲状旁腺疾病,又称甲状旁腺疾病,是指主要与主细胞腺瘤和家族性孤立性甲状旁腺功能减退症相关的甲状旁腺疾病。编码甲状旁腺激素的PTH基因在该疾病中起着核心作用,相关的生物学通路包括信号转导和类固醇代谢。该疾病与甲状腺和肾脏等组织相关,并通过涉及体内平衡/代谢以及生长/大小/身体部位的表型表现出来。对乙酰氨基酚和曲马多已被证实与该疾病相关,但其确切作用尚不清楚。 Parathyroid gland disease, also known as parathyroid disease, involves disorders of the parathyroid glands primarily associated with chief cell adenoma and familial isolated hypoparathyroidism. The PTH gene, encoding parathyroid hormone, plays a central role in this condition, with related biological pathways including signal transduction and steroid metabolism. The disease is linked to tissues such as the thyroid and kidney, and manifests through phenotypes involving homeostasis/metabolism and growth/size/body region. Acetaminophen and Tramadol have been noted in association with this disorder, although their precise role remains unclear.
共 5种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
CaSR agonist peptide-1

CaSR agonist peptide-1 是一种人源钙敏感受体 (CaSR) 激动剂,可通过与 CaSR 结合激活该受体,从而用于继发性甲状旁腺功能亢进的相关研究。

3057162-39-4
CaSR agonist peptide-1
Palopegteriparatide
Transcon PTH; ACP-014

Palopegteriparatide(Transcon PTH;ACP-014)是甲状旁腺激素 PTH (1-34) 的前药,无需补充钙和活性维生素 D 即可维持正常且稳定的钙浓度,可用于甲状旁腺功能减退症的相关研究。

2222514-07-8
Palopegteriparatide
PTH1R agonist 1

PTH1R agonist 1 (Example 2) 是一种甲状旁腺激素 1 受体 (PTH1R) 激动剂,可用于甲状旁腺功能减退症和骨质疏松症的研究。

3106336-35-7
PTH1R agonist 1
PTH1R agonist 2

PTH1R agonist 2 (example 3) 是一种甲状旁腺激素 1 受体 (PTH1R) 激动剂,可用于甲状旁腺功能减退症和骨质疏松症的研究。

3106850-44-3
PTH1R agonist 2
trans-Doxercalciferol
trans-度骨化醇

trans-Doxercalciferol 是 Doxercalciferol(MS-K59597)的异构体,而 Doxercalciferol 是一种维生素 D 受体激动剂,可减少蛋白尿、足细胞损伤、系膜扩张、细胞外基质蓄积、巨噬细胞浸润、氧化应激、促炎细胞因子、促纤维化生长因子、肾中性脂质蓄积、白蛋白尿及肾小球硬化,并可缓解高盐饮食诱导的心肌肥厚,因此 trans-Doxercalciferol 可用于饮食诱导肥胖相关肾病、糖尿病肾病、心肌肥厚、心功能障碍及继发性甲状旁腺功能亢进的研究。

74007-20-8
98.20%
trans-度骨化醇

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础